摘要
DNA甲基化属于表观遗传修饰的一种,是真核细胞DNA最普遍的修饰方式,可以通过影响基因突变、表达调控、细胞增殖等调节基因转录活性和表达。研究发现基因启动子甲基化的程度直接影响基因的转录活性,并且呈负相关。由于肿瘤的形成从本质上讲就是细胞原癌基因的激活和抑癌基因的失活所致,所以异常的DNA甲基化在致癌作用上扮演了重要角色。
出处
《临床医药实践》
2009年第3期163-165,共3页
Proceeding of Clinical Medicine
参考文献11
-
1Kang S, Kim J, Kim H B, et al. Methylation of p16INK4a is a non-rare event in cervical intraepithelial neoplasia [J]. Diagn Mol Pathol, 2006,15 ( 2 ) : 74- 82.
-
2Kitkumthorn N, Yanatatsanajit P, Kiatpongsan S, et al. Cyclin A1 promoter hypermethylation in human papillomavirus-assoeiated cervical cancer [J]. BMC Cancer,2006,8(6):55.
-
3Cheung T H,Lo K W,Yim S F,et al. Epigenetic and genetic alternation of PTEN in cervical neoplasm[J]. Gynecol Oncol, 2004,93 : 621-627.
-
4Liu S S,Chan K N,Leung R U,et at. Enhancement of the radiosensitivity of cervical cancer cells by overexpressing p73alpha[J]. Mol Cancer Ther,2006, 5(5)..1 209-1 215.
-
5Widschwendter A, Ivarsson L, Blassnig A ,et al. CDHI and CDH13 methylation in serum is an independent pmgnostic marker in cervical cancer patients [J]. Int J Cancer, 2004,109:163-166.
-
6Zambrano P, Segura-Pachcco B. A phase Ⅰ study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes [J]. BMC Cancer,2005(5):44.
-
7Zhang Z, Huetmer P C, Nguyen L, et al. Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer[J]. Oncogene, 2006,25(39): 5 436-5 445.
-
8Lee T S, Kim J W, Kang G H, et al. DNA hypomethylation of CAGE promotors in squamous cell carcinoma of uterine cervix [J]. Ann N Yacad Sci, 2006,1091: 218-224.
-
9Badal V,Chuang I. S,Tan E H,et al. CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression[J]. J Virol,2003,77(11): 6 227-6 234.
-
10Shuangshoti S,Hourpai N,Pumsuk U,et al. Line-1 hypomethylation in multistage carcinogenesis of the uterine cervix[J]. Asian Pac J Cancer Prey,2007,8 (2) :307-309.
同被引文献48
-
1Berger SL. The complex language of chromatin regulation during transcription [J]. Nature, 2007, 447(7143): 407-412.
-
2Bhattacharjee B, Sengupta S. CpG methylation of HPV 16 LCR at E2 binding site proximal to 1797 is associated with cervical cancer in presence of intact E2 [J]. Virology, 2006, 354(2): 280-285.
-
3Palefsky J. Biology of HPV in HIV infection [J]. Adv Dent Res, 2006, 19(1): 99-105.
-
4Burgers WA, Blanchon L, Pradhan S, et al. Viral oncoproteins target the DNA methyhransferases [J]. Oneogene, 2007, 26 (11 ): 1650- 1655.
-
5Klose R J, Bird AP. Genomic DNA methylation: the mark and its mediators [J]. Trends Biochem Sci, 2006, 31 (2): 89-97.
-
6Szalmas A, Konya J. Epigenetic alterations in cervical carcinogenesis [J]. Semin Cancer Biol, 2009, 19(3): 144-152.
-
7Yang H J, Liu VW, Wang Y, et al. Differential DNA methylation profiles in gynecological cancers and correlation with clinico- pathological data [J]. BMC Cancer, 2006, 6: 212.
-
8Henken FE, Wilting SM, Overmeer RM, et al. Sequential gene pro- moter methylation during HPV-induced cervical carcinogenesis [J]. BrJ Cancer, 2007, 97(10): 1457-1464.
-
9Zhang Z, Job K, Yatsuki H, et al. Rctinoic acid receptor beta7, is epigenetically silenced either by DNA methylation or repressive histane modifications at the promoter in cervical cancer cells [J]. Cancer Lett, 2007, 247(2): 318-327.
-
10Martinez I, Gardiner AS, Board KF, et al. Human papillomavims type 16 reduces the expression of microRNA-218 in cervical carci- noma cells [J ]. Oncogene, 2008, 27 ( 18): 2575-2582.
引证文献3
-
1邢洁,李阳,吕卫国,谢幸.宫颈癌发生过程中的表观遗传异常[J].国际妇产科学杂志,2011,38(4):311-315.
-
2彭平平,黄利鸣,韩钰,尤程程,方正超.重组天花粉蛋白高表达对人宫颈癌Caski细胞p73基因甲基化影响的机制研究[J].中国药理学通报,2013,29(9):1290-1293. 被引量:5
-
3郭琦,韩凤娟.基于表观遗传学探讨中医药防治宫颈癌的机制研究[J].中医药信息,2022,39(5):17-22. 被引量:2
二级引证文献7
-
1刘瑞娟,臧传鑫,李佳,赵文歌,孙长岗.基于肿瘤干细胞学说探究天花粉蛋白干预乳腺癌耐药株SP细胞的实验研究[J].中华中医药学刊,2018,36(12):2831-2834. 被引量:2
-
2张敏,朱卫丰,嵇琴,孙振,周莹,章明,彭淑红.抗肿瘤中药对DNA去甲基化作用的研究进展[J].中国实验方剂学杂志,2015,21(23):224-229. 被引量:6
-
3周海祥,卜平,董小耘,高云飞,孟杰依,邓心燕.天花粉蛋白抗肿瘤作用及机制的研究进展[J].医学综述,2017,23(16):3197-3201. 被引量:5
-
4金巧智,李志海,蔡志毅,陈武兵,王雪.天花粉蛋白诱导Syk(L)基因去甲基化抑制喉癌Hep-2细胞生长研究[J].医学研究杂志,2018,47(3):51-56. 被引量:5
-
5郭琦,韩凤娟.基于表观遗传学探讨中医药防治宫颈癌的机制研究[J].中医药信息,2022,39(5):17-22. 被引量:2
-
6王跃,高慧,刘玉兰,郝艳红,扈有芹,李青波.子宫颈高危型人乳头瘤病毒感染的中西医治疗研究进展[J].世界中医药,2024,19(2):236-243. 被引量:1
-
7吴莹,李媛,王晓燕.血府逐瘀汤联合西医化疗对气滞血瘀证晚期子宫颈癌患者近期疗效及生存期的影响[J].中外医学研究,2024,22(20):139-142.
-
1谢坤,朱立新.DNA甲基化与肝癌的关系[J].国际肿瘤学杂志,2006,33(3):220-222. 被引量:2
-
2杨丽敏,张秀丽,云玉珍.c-myc反义寡核苷酸诱导肝癌细胞凋亡的研究[J].中国肿瘤生物治疗杂志,2002,9(3):193-193. 被引量:3
-
3杨伊林,邵耐远,徐宁,李璐,罗光华.人脑胶质瘤中PTEN基因表达的实时定量PCR[J].江苏医药,2004,30(11):864-865.
-
4江培洲,沈新明,黄华.癌基因与抑癌基因的表达研究进展[J].国外医学(肿瘤学分册),2001,28(2):89-92. 被引量:11
-
5欧春怡.甲基化与妇科肿瘤的研究进展[J].国外医学(妇产科学分册),2002,29(6):367-370.
-
6李潇.细胞原癌基因的表达与调控[J].基础医学与临床,1991,11(6):337-340. 被引量:4
-
7高春宇,杨玉华.DNA甲基化与肿瘤[J].国外医学(遗传学分册),2003,26(5):249-251.
-
8李培坤,耿小平,朱立新.DNA甲基化抑制剂研究进展[J].国际药学研究杂志,2010,37(3):198-202. 被引量:17
-
9李宁,孙正.口腔癌发展机制和生物标志物[J].国外医学(卫生学分册),2002,29(3):149-152.
-
10杨彦,兰平.血管生成素-2和生存素在胃癌中的研究进展[J].中华临床医师杂志(电子版),2009,3(4):63-67. 被引量:2